These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9745356)

  • 1. Receptor targets in William Tell country: insights into receptor biology using fluorescent proteins.
    Mills A
    Trends Pharmacol Sci; 1998 Aug; 19(8):305-7. PubMed ID: 9745356
    [No Abstract]   [Full Text] [Related]  

  • 2. Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach.
    Gupte J; Cutler G; Chen JL; Tian H
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1508-13. PubMed ID: 14757815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein origami: therapeutic rescue of misfolded gene products.
    Conn PM; Leaños-Miranda A; Janovick JA
    Mol Interv; 2002 Sep; 2(5):308-16. PubMed ID: 14993385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptors: Structural and mechanistic insights into pharmacology and signaling.
    Shang Y; Filizola M
    Eur J Pharmacol; 2015 Sep; 763(Pt B):206-13. PubMed ID: 25981301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Receptors of hepatic stellate cells: new insights and prospects for therapy].
    Shen F; Yin C; Jia J; Wang B
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):479-80. PubMed ID: 12502466
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the carboxyl-terminal region, di-leucine motif and cysteine residues in signalling and internalization of vasopressin V1a receptor.
    Preisser L; Ancellin N; Michaelis L; Creminon C; Morel A; Corman B
    FEBS Lett; 1999 Oct; 460(2):303-8. PubMed ID: 10544254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adventures in drug discovery: potent agents based on ligands for cell-surface receptors.
    Maryanoff BE
    Acc Chem Res; 2006 Nov; 39(11):831-40. PubMed ID: 17115723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping peptide antagonist binding sites of the human V1a and V2 vasopressin receptors.
    Mouillac B; Phalipou S; Cotte N; Balestre MN; Hibert M; Manning M; Barberis C
    Adv Exp Med Biol; 1998; 449():359-61. PubMed ID: 10026825
    [No Abstract]   [Full Text] [Related]  

  • 9. The importance of acidic amino acid residues in the binding of ligands to the V1a vasopressin receptor.
    Davies AR; Wheatley M
    Biochem Soc Trans; 1995 Feb; 23(1):85S. PubMed ID: 7758805
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method.
    Filizola M; Olmea O; Weinstein H
    Protein Eng; 2002 Nov; 15(11):881-5. PubMed ID: 12538907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anterior pituitary LH-RH receptor (author's transl)].
    Ogawa N; Yamawaki T; Kuroda H; Ofuji M
    Horumon To Rinsho; 1980 Aug; 28(8):889-97. PubMed ID: 6257430
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular docking-based test for affinities of two ligands toward vasopressin and oxytocin receptors.
    Slusarz R; Kaźmierkiewicz R; Giełdoń A; Lammek B; Ciarkowski J
    Acta Biochim Pol; 2001; 48(1):131-5. PubMed ID: 11440162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor oligomerization. Detection and functional characterization of interacting receptors.
    Gomes I; Filipovska J; Devi LA
    Methods Mol Med; 2003; 84():157-83. PubMed ID: 12703323
    [No Abstract]   [Full Text] [Related]  

  • 14. Defining the ligand-binding site for vasopressin receptors: a peptide mimetic approach.
    Howl J; Parslow RA; Wheatley M
    Biochem Soc Trans; 1995 Feb; 23(1):103-8. PubMed ID: 7758661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in the research of oxytocin and its receptor].
    Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):711-6. PubMed ID: 8396612
    [No Abstract]   [Full Text] [Related]  

  • 16. Aberrant receptor-mediated Cushing's syndrome.
    Bertagna X; Groussin L; Luton JP; Bertherat J
    Horm Res; 2003; 59 Suppl 1():99-103. PubMed ID: 12638519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of putative glycosylation sites in the extracellular loops of the vasopressin V1a receptor.
    Hawtin SR; Davies AR; Matthews G; Wheatley M
    Biochem Soc Trans; 1997 Aug; 25(3):435S. PubMed ID: 9388659
    [No Abstract]   [Full Text] [Related]  

  • 19. Signal transmission via G protein-coupled receptors in the light of rhodopsin structure determination.
    Ciarkowski J; Drabik P; Giełdoń A; Kaźmierkiewicz R; Slusarz R
    Acta Biochim Pol; 2001; 48(4):1203-7. PubMed ID: 11995993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte modulation by seven transmembrane receptors: a brief review of session 1.
    Sharp BM
    Adv Exp Med Biol; 2001; 493():255-8. PubMed ID: 11727774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.